Healthcare Services Group Inc
HCSGNasdaqCIK 731012HealthcareFiscal year ends Dec 31
Reports and events: 210 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2316:04 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0000731012-26-000059 |
| 2026-10-2107:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000731012-26-000055 |
| 2026-10-0717:00 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000731012-26-000052 |
| 2026-07-2416:04 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0000731012-26-000046 |
| 2026-07-2207:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000731012-26-000040 |
| 2026-05-2716:14 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000731012-26-000036 |
| 2026-04-2417:20 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0000731012-26-000031 |
| 2026-04-2207:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000731012-26-000025 |
| 2026-04-1517:04 ET | DEF 14A | Proxy statementPeriod 2026-05-26 | 0000731012-26-000021 |
| 2026-04-1317:28 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000731012-26-000015 |
| 2026-02-1316:27 ET | 10-K | Annual reportPeriod 2025-12-31 | 0000731012-26-000009 |
| 2026-02-1107:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000731012-26-000004 |
| 2025-10-2416:02 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0000731012-25-000108 |
| 2025-10-2207:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000731012-25-000104 |
| 2025-07-2516:03 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000731012-25-000100 |
| 2025-07-2307:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000731012-25-000097 |
| 2025-07-1014:49 ET | 8-K | 7.01 Regulation FD disclosure | 0000731012-25-000094 |
| 2025-05-2816:28 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000731012-25-000068 |
| 2025-04-2516:02 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000731012-25-000066 |
| 2025-04-2307:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000731012-25-000062 |
| 2025-04-1416:24 ET | DEF 14A | Proxy statementPeriod 2025-05-27 | 0000731012-25-000058 |
| 2025-02-1416:04 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000731012-25-000032 |
| 2025-02-1207:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000731012-25-000024 |
| 2024-10-2516:03 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000731012-24-000142 |
| 2024-10-2307:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000731012-24-000139 |
| 2024-10-1617:07 ET | 8-K | 8.01 Other events | 0000731012-24-000134 |
| 2024-09-0916:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000731012-24-000118 |
| 2024-07-2616:08 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000731012-24-000114 |
| 2024-07-2407:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000731012-24-000110 |
| 2024-06-0317:21 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000731012-24-000097 |
| 2024-05-2917:06 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000731012-24-000078 |
| 2024-04-2616:21 ET | DEF 14A | Proxy statementPeriod 2024-05-28 | 0000731012-24-000067 |
| 2024-04-2616:13 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000731012-24-000065 |
| 2024-04-2407:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000731012-24-000059 |
| 2024-02-1616:27 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000731012-24-000025 |
| 2024-02-1407:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000731012-24-000019 |
| 2023-10-2716:33 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000731012-23-000119 |
| 2023-10-2507:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000731012-23-000115 |
| 2023-07-2816:31 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000731012-23-000103 |
| 2023-07-2607:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000731012-23-000098 |
| 2023-06-0117:29 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000731012-23-000090 |
| 2023-04-2816:37 ET | DEF 14A | Proxy statementPeriod 2023-04-28 | 0000731012-23-000067 |
| 2023-04-2816:32 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000731012-23-000065 |
| 2023-04-2607:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000731012-23-000047 |
| 2023-02-1717:28 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000731012-23-000024 |
| 2023-02-1617:28 ET | 8-K | 8.01 Other events | 0000731012-23-000020 |
| 2023-02-1507:09 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000731012-23-000016 |
| 2022-11-2817:04 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000731012-22-000089 |
| 2022-10-2117:01 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000731012-22-000084 |
| 2022-10-1907:04 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000731012-22-000081 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 13:40 ET. Listed shows no prices and gives no investment advice.